Come up with a name for your new list and we'll add to it:
Immunocore raised a round of funding on September 18, 2017. Investors include
Bill & Melinda Gates Foundation.
Immunocore is a biotechnology company, with a highly innovative immuno-oncology platform technology called ImmTACs. ImmTACs are a novel class of biologic drugs based on the Company's proprietary T cel…